Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026

Bulletin Express04-23

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.

The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.

For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.

Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.

The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123642963?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123642963","market":"hk","top_or_hot":-1,"title":"Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026","media":"Bulletin Express","content":"<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.</p>\n<p>The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.</p>\n<p>For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.</p>\n<p>Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.</p>\n<p>The dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.</p>\n<p>For overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.</p>\n<p>Jiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.</p>\n<p>The board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02566","symbol_name":"九源基因","start_time":0,"source_url":"","article_id":"1123642963","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123642963","pubTimestamp":1776951823,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02566":"九源基因"},"translate_title":"玖源基因宣派2025财年末期股息每10股人民币0.57元；预计于2026年7月30日付款","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year ended 31 December 2025. The distribution was approved by shareholders on 15 June 2026 and will be paid on 30 July 2026.\nThe dividend timetable is as follows: ex-dividend trading commences on 17 June 2026, the last day to lodge share transfers is 18 June 2026 (16:30), books will be closed from 22 June 2026 to 24 June 2026, and the record date is set for 24 June 2026. Payment details, including the default payout currency and applicable exchange rate for Hong Kong shareholders, will be announced separately.\nFor overseas non-resident enterprise shareholders—covering all H shares registered in the name of HKSCC Nominees Limited except those held on behalf of investors via H-share full circulation—a 10% enterprise income tax will be withheld and remitted by the company. Further information is provided in the “DIVIDEND TAX” section of the 2025 Annual Report.\nJiuyuan Gene’s issued share capital stands at 241,516,400 shares, excluding 3,882,400 treasury shares; treasury shares are ineligible for the dividend.\nThe board currently comprises two executive directors (Mr. Fu Hang and Mr. Zhou Wei), four non-executive directors (Mr. Wu Shihang, Mr. Albert Esteve Cruella, Mr. Fei Junjie, and Ms. Yan Weiting), and three independent non-executive directors (Mr. Zhou Zhihui, Ms. Ho Mei Yi, and Dr. Zhou Demin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123642963","isCrawlerRequest":true}